Suchergebnisse - "Dogné, Jean-Michel"

PubPharm (19)

1

Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Simon, G. | Favresse, J. | Gillot, C. | +6

2

Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals : importance of the timing

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Gillot, C. | Bayart, J. | Closset, M. | +5

3

Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster

enthalten in: Journal of medical virology | 2023

von Favresse, J. | Gillot, C. | Bayart, J. | +6

4

Assessment of the humoral response in Omicron breakthrough cases in healthcare workers who received the BNT162b2 booster

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Favresse, J. | Dogné, J. | Douxfils, J.

5

Spike vs. nucleocapsid serum antigens for COVID-19 diagnosis and severity assessment

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Favresse, J. | Bayart, J. | David, C. | +4

6

Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity

enthalten in: The Journal of infection | 2022

von Favresse, J. | Bayart, J. | David, C. | +2

7

Antibody titres decline 3-month post-vaccination with BNT162b2

enthalten in: Emerging microbes & infections | 2021

von Favresse, J. | Bayart, J. | Mullier, F. | +9

8

Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects

enthalten in: Viruses | 2021

von Gillot, C. | Favresse, J. | Maloteau, V. | +2

9

Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Favresse, J. | Bayart, J. | Mullier, F. | +3

10

Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2

enthalten in: Viruses | 2021

von Favresse, J. | Gillot, C. | Di Chiaro, L. | +7